First Postoperative Day Review After Uneventful Phacoemulsification

This study has been completed.
Sponsor:
Information provided by:
Veroia General Hospital
ClinicalTrials.gov Identifier:
NCT01247155
First received: November 23, 2010
Last updated: NA
Last verified: April 2009
History: No changes posted
  Purpose

The purpose of this randomized trial was to examine the value of the review on the first postoperative day after uneventful phacoemulsification cataract surgery.


Condition
Phacoemulsification
Complications
BCVA

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective

Further study details as provided by Veroia General Hospital:

Primary Outcome Measures:
  • Best corrected visual acuity

Groups/Cohorts
first day review
non-first day review

  Eligibility

Ages Eligible for Study:   65 Years to 90 Years
Genders Eligible for Study:   Both
Sampling Method:   Probability Sample
Study Population

291 consecutive patients who underwent uneventful phacoemulsification cataract surgery were randomized into two groups: i) Next day review (NDR group, n=146) and ii) No next day review (NNDR group, n=145).

Criteria

Inclusion Criteria:

Exclusion Criteria:

Exclusion criteria were the following:

i) intra-operative complications, such as posterior capsule rupture, vitreous loss, lost nucleus, zonule dehiscence and wound leak,

ii) inadequate social support for overnight care at home,

iii) severely limited visual potential in the fellow eye,

iv) uveitis or ocular trauma,

v) severe systemic diseases limiting activity,

vi) patients with learning disability or dementia.

  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01247155

Locations
Greece
General Hospital of Veroia
Veroia, Imathia, Greece, 59100
Sponsors and Collaborators
Veroia General Hospital
  More Information

No publications provided by Veroia General Hospital

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT01247155     History of Changes
Other Study ID Numbers: 9151
Study First Received: November 23, 2010
Last Updated: November 23, 2010
Health Authority: Greece: Ethics Committee

ClinicalTrials.gov processed this record on September 16, 2014